DK1077703T3 - Orale lægemiddelformer med reproducerbar frisættelse af gatifloxacin eller farmaceutisk anvendelige salte eller hydrater deraf - Google Patents

Orale lægemiddelformer med reproducerbar frisættelse af gatifloxacin eller farmaceutisk anvendelige salte eller hydrater deraf

Info

Publication number
DK1077703T3
DK1077703T3 DK99923491T DK99923491T DK1077703T3 DK 1077703 T3 DK1077703 T3 DK 1077703T3 DK 99923491 T DK99923491 T DK 99923491T DK 99923491 T DK99923491 T DK 99923491T DK 1077703 T3 DK1077703 T3 DK 1077703T3
Authority
DK
Denmark
Prior art keywords
gatifloxacin
hydrates
oral pharmaceutical
pharmaceutical forms
pharmaceutically usable
Prior art date
Application number
DK99923491T
Other languages
Danish (da)
English (en)
Inventor
Johannes Bartholomaeus
Juergen Betzing
Original Assignee
Gruenenthal Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Gruenenthal Gmbh filed Critical Gruenenthal Gmbh
Application granted granted Critical
Publication of DK1077703T3 publication Critical patent/DK1077703T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/4709—Non-condensed quinolines and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DK99923491T 1998-05-09 1999-04-29 Orale lægemiddelformer med reproducerbar frisættelse af gatifloxacin eller farmaceutisk anvendelige salte eller hydrater deraf DK1077703T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19820801A DE19820801A1 (de) 1998-05-09 1998-05-09 Orale Arzneiformen mit reproduzierbarer Wirkstofffreisetzung von Gatifloxacin oder pharmazeutisch verwendbaren Salzen oder Hydraten
PCT/EP1999/002893 WO1999058129A1 (de) 1998-05-09 1999-04-29 Orale arzneiformen mit reproduzierbarer wirkstofffreisetzung von gatifloxacin oder pharmazeutisch verwendbaren salzen oder hydraten

Publications (1)

Publication Number Publication Date
DK1077703T3 true DK1077703T3 (da) 2003-06-23

Family

ID=7867223

Family Applications (1)

Application Number Title Priority Date Filing Date
DK99923491T DK1077703T3 (da) 1998-05-09 1999-04-29 Orale lægemiddelformer med reproducerbar frisættelse af gatifloxacin eller farmaceutisk anvendelige salte eller hydrater deraf

Country Status (28)

Country Link
US (1) US6291462B1 (pt)
EP (1) EP1077703B1 (pt)
JP (1) JP2002514600A (pt)
KR (1) KR100587210B1 (pt)
CN (1) CN1198615C (pt)
AR (1) AR019279A1 (pt)
AT (1) ATE235242T1 (pt)
AU (1) AU753482B2 (pt)
BR (1) BR9910350A (pt)
CA (1) CA2325636A1 (pt)
CO (1) CO5050341A1 (pt)
DE (2) DE19820801A1 (pt)
DK (1) DK1077703T3 (pt)
ES (1) ES2195573T3 (pt)
HK (1) HK1033281A1 (pt)
HU (1) HUP0101597A3 (pt)
IL (1) IL139512A0 (pt)
MY (1) MY118569A (pt)
NO (1) NO20005385D0 (pt)
NZ (1) NZ507968A (pt)
PE (1) PE20000480A1 (pt)
PL (1) PL343936A1 (pt)
PT (1) PT1077703E (pt)
RU (1) RU2226394C2 (pt)
SK (1) SK16772000A3 (pt)
UA (1) UA60364C2 (pt)
WO (1) WO1999058129A1 (pt)
ZA (1) ZA200006440B (pt)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CZ302015B6 (cs) 1999-10-08 2010-09-08 Affinium Pharmaceuticals, Inc. Inhibitory Fab I
US6413969B1 (en) * 2000-09-13 2002-07-02 Bristol-Myers Squibb Company Gatifloxacin pentahydrate
ATE420640T1 (de) * 2001-04-06 2009-01-15 Affinium Pharm Inc Fab-i-inhibitoren
US6589955B2 (en) * 2001-06-20 2003-07-08 Bristol-Myers Squibb Company Pediatric formulation of gatifloxacin
DK1575951T3 (da) * 2002-12-06 2014-09-15 Debiopharm Int Sa Heterocykliske forbindelser, fremgangsmåder til fremstilling deraf og deres anvendelse i terapi
EP1608377B1 (en) 2003-03-17 2008-10-01 Affinium Pharmaceuticals, Inc. Pharmaceutical compositions comprising inhibitors of fab i and further antibiotics
US20050031683A1 (en) * 2003-08-04 2005-02-10 Ashish Kapoor Solid pharmaceutical composition
WO2005021000A1 (en) * 2003-08-28 2005-03-10 Ranbaxy Laboratories Limited Solid oral dosage forms of gatifloxacin
MY144477A (en) * 2004-03-17 2011-09-30 Novartis Ag Galenic formulations of organic compounds
SI1828167T1 (sl) * 2004-06-04 2014-12-31 Debiopharm International Sa Forum "Apres-Demain" Akrilamidni derivati kot anitibiotična sredstva
US20060247255A1 (en) * 2005-05-02 2006-11-02 Patel Satishkumar A Method for preparing a stable gatifloxacin composition
CA2617230A1 (en) * 2005-08-02 2007-02-08 Baxter International Inc. Medical products and parenteral formulations
WO2007067416A2 (en) * 2005-12-05 2007-06-14 Affinium Pharmaceuticals, Inc. Heterocyclylacrylamide compounds as fabi inhibitors and antibacterial agents
EP2054422B1 (en) 2006-07-20 2017-06-14 Debiopharm International SA Acrylamide derivatives as fab i inhibitors
CN100415212C (zh) * 2006-07-21 2008-09-03 哈药集团制药总厂 一种含乳酸卡德沙星的口服制剂
CA2563690C (en) * 2006-10-12 2014-10-07 Pharmascience Inc. Pharmaceutical compositions comprising intra- and extra- granular fractions
WO2008098374A1 (en) 2007-02-16 2008-08-21 Affinium Pharmaceuticals, Inc. Salts, prodrugs and polymorphs of fab i inhibitors
MX356695B (es) 2012-06-19 2018-06-11 Debiopharm Int Sa Profarmacos derivados de (e)-n-metil-n-((3-metilbenzofuran-2-il)me til)-3-(7-oxo-5,6,7,8-tetrahidro-1,8-naftiridin-3-il) acrilamida.
KR20180114177A (ko) 2016-02-26 2018-10-17 데비오팜 인터네셔날 에스 에이 당뇨병성 족부 감염의 치료제

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH089597B2 (ja) 1986-01-21 1996-01-31 杏林製薬株式会社 選択毒性に優れた８‐アルコキシキノロンカルボン酸およびその塩並びにその製造方法
EP0522128B1 (en) * 1991-01-30 1996-01-17 The Wellcome Foundation Limited Water-dispersible tablets
GB9109862D0 (en) * 1991-05-08 1991-07-03 Beecham Lab Sa Pharmaceutical formulations
US5436253A (en) * 1993-09-08 1995-07-25 Daiichi Pharmaceutical Co., Ltd. Pyridonecarboxylic acid derivatives and mycotic infections
US5858411A (en) * 1994-12-19 1999-01-12 Daiichi Pharmaceutical Co., Ltd. Sustained-release granular preparations and production process thereof
US5945124A (en) * 1995-07-05 1999-08-31 Byk Gulden Chemische Fabrik Gmbh Oral pharmaceutical composition with delayed release of active ingredient for pantoprazole
US5837292A (en) * 1996-07-03 1998-11-17 Yamanouchi Europe B.V. Granulate for the preparation of fast-disintegrating and fast-dissolving compositions containing a high amount of drug

Also Published As

Publication number Publication date
MY118569A (en) 2004-12-31
IL139512A0 (en) 2001-11-25
US6291462B1 (en) 2001-09-18
PT1077703E (pt) 2003-08-29
NO20005385L (no) 2000-10-26
PL343936A1 (en) 2001-09-10
NO20005385D0 (no) 2000-10-26
ATE235242T1 (de) 2003-04-15
HK1033281A1 (en) 2001-08-24
PE20000480A1 (es) 2000-05-20
ES2195573T3 (es) 2003-12-01
EP1077703A1 (de) 2001-02-28
JP2002514600A (ja) 2002-05-21
KR20010043408A (ko) 2001-05-25
KR100587210B1 (ko) 2006-06-08
HUP0101597A3 (en) 2003-01-28
BR9910350A (pt) 2001-09-25
NZ507968A (en) 2002-12-20
UA60364C2 (uk) 2003-10-15
HUP0101597A2 (hu) 2001-11-28
SK16772000A3 (sk) 2001-05-10
WO1999058129A1 (de) 1999-11-18
CN1198615C (zh) 2005-04-27
AU4035299A (en) 1999-11-29
CN1300216A (zh) 2001-06-20
DE19820801A1 (de) 1999-11-25
AR019279A1 (es) 2002-02-13
EP1077703B1 (de) 2003-03-26
AU753482B2 (en) 2002-10-17
CO5050341A1 (es) 2001-06-27
CA2325636A1 (en) 1999-11-18
DE59904737D1 (de) 2003-04-30
RU2226394C2 (ru) 2004-04-10
ZA200006440B (en) 2002-02-08

Similar Documents

Publication Publication Date Title
DK1077703T3 (da) Orale lægemiddelformer med reproducerbar frisættelse af gatifloxacin eller farmaceutisk anvendelige salte eller hydrater deraf
DK1435915T3 (da) Orale doseringsformer til propiverin eller farmaceutisk acceptable salte deraf med en forsinket afgivelse af en aktiv bestanddel
DK1674084T3 (da) Forlænget frigivelse af oral dosissammensætning
DK1163207T3 (da) Forbedret fremgangsmåde til fremstillingen af ikke-hygroskopiske salte af L(-)-carnitin
DK1207867T3 (da) Retarderede, orale farmaceutiske indgivelsesformer med tramadol
DK1273575T3 (da) Diazepan derivater eller salte deraf
DK1196409T3 (da) Respiratoriske syncytilvirusreplikationsinhibitorer
ATE276244T1 (de) Replikationsinhibitoren des respiratorischen synzytialvirus
EE200100259A (et) Moksifloksatsiini farmatseutiline preparaat
EE05400B1 (et) Prasoolderivaadid, neid v?i nende farmatseutiliselt vastuv?etavaid sooli, solvaate v?i derivaate sisaldavad farmatseutilised kompositsioonid, nende kasutamine ning meetodid nende valmistamiseks
PT1189916E (pt) N-pirazole agonistas do receptor a2a
NO20021747D0 (no) Blandinger av erytromycinderivater med forlenget frigivelse
NO20030213D0 (no) Anvendelse av D2/D3 reseptor-agonister for behandling av fibromyalgi
DK1221952T3 (da) Anvendelse af en antagonist til centrale cannaboidreceptorer med henblik på fremstilling af lægemidler
DK1445249T3 (da) Nye bensophenon-derivater eller salte deraf
DK1140034T3 (da) Formulering af divalproex-natrium med kontrolleret frigivelse
NO20021540L (no) Sammensetninger med kontrollert frigivelse omfattende nimesulfid
DK1736158T3 (da) Anvendel af 1- 4-(5-cyanoindol-3-yl)butyl -4-(2-carbamoylbenzofuran-5-yl)piperazin samt de fysiologiske acceptable salte deraf
DK1230230T3 (da) Derivater af indeno-dihydrothiazol, fremstilling deraf og anvendelse som anorektiske lægemidler
EE200100383A (et) L-fenüülefriinvesinikkloriidi valmistamise meetod
PT1237559E (pt) Combinacoes farmaceuticas compreendendo um antagonista do receptor p2t e megalatrano
NO20001375D0 (no) Legemiddelformulering med kontrollert virkestoffrigivning
FR2775901B1 (fr) Sels de cetoacides et de derives amines, et leur utilisation pour la preparation de medicaments
DK1274427T3 (da) Formulering af substituerede benzimidazoler
NO20013145D0 (no) Anvendelse av Na-H-bytter-inhibitorer for fremstilling av medikamenter